Inhibition of the Type 2 Iodothyronine Deiodinase Underlies the Elevated Plasma TSH Associated with Amiodarone Treatment
Open accessAbstract
The widely prescribed cardiac antiarrhythmic drug amiodarone (AMIO) and its main metabolite, desethylamiodarone (DEA), have multiple side effects on thyroid economy, including an elevation in serum TSH levels. To study the AMIO effect on TSH, mice with targeted disruption of the type 2 deiodinase gene (D2KO) were treated with 80 mg/kg AMIO for 4 wk. Only wild-type (WT) mice controls developed the expected approximate twofold rise in plasma TSH, illustrating a critical role for D2 in this mechanism. A disruption in the D2 pathway caused by AMIO could interfere with the transduction of the T4 signal, generating less T3 and softening the TSH feedback mechanism. When added directly to sonicates of HEK-293 cells transiently expressing D2, both AMIO and DEA behaved as noncompetitive inhibitors of D2 [IC(50) of >100 μm and ∼5 μm, respectively]. Accordingly, D2 activity was significantly decreased in the median eminence and anterior pituitary sonicates of AMIO-treated mice. However, the underlying effect on TSH is likely to be at the pituitary gland given that in AMIO-treated mice the paraventricular TRH mRNA levels (which are negatively regulated by D2-generated T3) were decreased. In contrast, AMIO and DEA both exhibited dose-dependent inhibition of D2 activity and elevation of TSH secretion in intact TαT1 cells, a pituitary thyrotroph cell line used to model the TSH feedback mechanism. In conclusion, AMIO and DEA are noncompetitive inhibitors of D2, with DEA being much more potent, and this inhibition at the level of the pituitary gland contributes to the rise in TSH seen in patients taking AMIO.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A need for increased LT4 dose was reported with initiation of amiodarone therapy in two patients, and amiodarone inhibits D2 in rodents.
“With respect to agents that alter D2 activity, a need for an increased dose of LT4 was reported with initiation of amiodarone therapy in two patients (192), and this drug has been shown to inhibit D2 in rodents (193).”
From Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014) · cites this paper as [193]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling1
Gereben, B., Zavacki, A. M., Ribich, S., Kim, B. W., Huang, S. A., Simonides, W. S., Zeöld, A., & Bianco, A. C. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0019 · Cited by 891 · see citing works
Self-citationThe Effects of Amiodarone on the Thyroid
Martino, E., Bartalena, L., Bogazzi, F., & Braverman, L. E. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0427 · Cited by 559 · see citing works
Holt, D. W., Tucker, G. T., Jackson, P. R., & Storey, G. (1983) · American Heart Journal · doi:10.1016/0002-8703(83)90006-6 · Cited by 410 · see citing works
Schneider, M. J., Fiering, S. N., Pallud, S. E., Parlow, A. F., St. Germain, D. L., & Galton, V. A. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.12.0740 · Cited by 376 · see citing works
Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans
Luiza Maia, A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25083 · Cited by 360 · see citing works
Burger, A., Dinichert, D., NICOD, P. H., Jenny, M., Lemarchand-Béraud, T., & Vallotton, M. B. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108466 · Cited by 311 · see citing works
Tu, H. M., Kim, S.-W., Salvatore, D., Bartha, T., Legradi, G., Larsen, P. R., & Lechan, R. M. (1997) · Endocrinology · doi:10.1210/endo.138.8.5318 · Cited by 302 · see citing works
Self-citationBalsam, A., Ingbar, S. H., & SEXTON, F. C. (1978) · Journal of Clinical Investigation · doi:10.1172/jci109143 · Cited by 168 · see citing works
Neuropeptide Y has a central inhibitory action on the hypothalamic-pituitary-thyroid axis
Fekete, C., Kelly, J., Mihály, E., Sarkar, S., Rand, W. M., Légrádi, G., Emerson, C. H., & Lechan, R. M. (2001) · Endocrinology · doi:10.1210/endo.142.6.8207 · Cited by 167 · see citing works
Self-citationFreitas, B. C. G., Gereben, B., Castillo, M., Kalló, I., Zeöld, A., Egri, P., Liposits, Z., Zavacki, A. M., Maciel, R. M. B., Jo, S., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41977 · Cited by 160 · see citing works
Self-citationMelmed, S. K., Nademanee, K., REED, A. W., Hendrickson, J. A., Singh, B. N., & Hershman, J. M. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-5-997 · Cited by 157 · see citing works
Fekete, C., & Lechan, R. M. (2007) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.04.002 · Cited by 137 · see citing works
Self-citationNademanee, K., Singh, B. N., Hendrickson, J., Reed, A. W., Melmed, S., & Hershman, J. M. (1982) · Circulation · doi:10.1161/01.cir.66.1.202 · Cited by 135 · see citing works
Christoffolete, M. A., Ribeiro, R., Singru, P., Fekete, C., da Silva, W. S., Gordon, D. F., Huang, S. A., Crescenzi, A., Harney, J. W., Ridgway, E. C., et al. (2006) · Endocrinology · doi:10.1210/en.2005-1300 · Cited by 118 · see citing works
Self-citationThyroid Hormone Regulates Type I Deiodinase Messenger RNA in Rat Liver
Berry, M. J., Kates, A., & Larsen, P. R. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-5-743 · Cited by 117 · see citing works
Sogol, P. B., Hershman, J. M., REED, A. W., & DILLMANN, W. H. (1983) · Endocrinology · doi:10.1210/endo-113-4-1464 · Cited by 108 · see citing works
Krenning, E. P., Docter, R., Bernard, B. F., Visser, T. J., & HENNEMANN, G. (1982) · FEBS Letters · doi:10.1016/0014-5793(82)80900-9 · Cited by 95 · see citing works
Regulation of Type 1 Iodothyronine Deiodinase in Health and Disease
Koenig, R. J. (2005) · Thyroid · doi:10.1089/thy.2005.15.835 · Cited by 90 · see citing works
Kaplan, M. M., Pan, C., Gordon, P., Lee, J., & Gilchrest, B. A. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-4-815 · Cited by 73 · see citing works
Bakker, O., van Beeren, H. C., & Wiersinga, W. M. (1994) · Endocrinology · doi:10.1210/endo.134.4.8137729 · Cited by 68 · see citing works
Kádár, A., Sánchez, E., Wittmann, G., Singru, P. S., Füzesi, T., Marsili, A., Larsen, P. R., Liposits, Z., Lechan, R. M., & Fekete, C. (2010) · Journal of Comparative Neurology · doi:10.1002/cne.22432 · Cited by 66 · see citing works
Self-citationPharmacokinetics and body distribution of amiodarone in man.
Plomp, T. A., van Rossum, J. M., de Medina, E. O. R., Lier, T. V., & Maes, R. A. A. (1984) · PubMed · Cited by 65 · see citing works
van Beeren, H. C., Bakker, O., & Wiersinga, W. M. (1995) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(95)03578-u · Cited by 62 · see citing works
Amiodarone Inhibits the Conversion of Thyroxine to Triiodothyronine in Isolated Rat Hepatocytes
Aanderud, S., Sundsfjord, J., & Aarbakke, J. (1984) · Endocrinology · doi:10.1210/endo-115-4-1605 · Cited by 54 · see citing works
Bouter, S. L., Harchi, A. E., Marionneau, C., Bellocq, C., Chambellan, A., van Veen, T. A. B., Boixel, C., Gavillet, B., Abriel, H., Quang, K. L., et al. (2004) · Circulation · doi:10.1161/01.cir.0000147187.78162.ac · Cited by 49 · see citing works
Yusta, B., Alarid, E. T., Gordon, D. F., Ridgway, E. C., & Mellon, P. L. (1998) · Endocrinology · doi:10.1210/endo.139.11.6283 · Cited by 46 · see citing works
Thyroxine and triiodothyronine kinetics in cardiac patients taking amiodarone
Hershman, J. M., Nademanee, K., Sugawara, M., Pekary, A. E., Ross, R., Singh, B. N., & DiStefano, J. J. (1986) · European Journal of Endocrinology · doi:10.1530/acta.0.1110193 · Cited by 45 · see citing works
A consensus report on antiarrhythmic drug use
Reiffel, J. A., Estes, N. A. M., Waldo, A. L., Prystowsky, E. N., & DiBianco, R. (1994) · Clinical Cardiology · doi:10.1002/clc.4960170303 · Cited by 42 · see citing works
Falik, R., Flores, B. T., Shaw, L. M. J., Gibson, G. A., Josephson, M. E., & Marchlinski, F. E. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90211-7 · Cited by 40 · see citing works
Structure-effect relationships of amiodarone analogues on the inhibition of thyroxine deiodination
Ha, H. R., Stieger, B., Grassi, G., Altorfer, H. R., & Folláth, F. (2000) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050701 · Cited by 38 · see citing works
SUZUKI, H., KADENA, N., Takeuchi, K., & Nakagawa, S. (1979) · European Journal of Endocrinology · doi:10.1530/acta.0.0920477 · Cited by 37 · see citing works
Safran, M., Fang, S.-L., Bambini, G., Pinchera, A., Martino, E., & Braverman, L. E. (1986) · The American Journal of the Medical Sciences · doi:10.1097/00000441-198609000-00003 · Cited by 32 · see citing works
Desethylamiodarone antagonizes the effect of thyroid hormone at the molecular level
Bogazzi, F., Bartalena, L., Brogioni, S., Burelli, A., Raggi, F., Ultimieri, F., Cosci, C., Vitale, M., Fenzi, G., & Martino, E. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450059 · Cited by 30 · see citing works
Amiodarone‐induced hypercholesterolemia is associated with a decrease in liver LDL receptor mRNA
Hudig, F., Bakker, O., & Wiersinga, W. M. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80245-9 · Cited by 28 · see citing works
Effects of amiodarone on 5′-deiodination of thyroxine to tri-iodothyronine in rat myocardium
Ceppi, J. A., & Zaninovich, Á. A. (1989) · Journal of Endocrinology · doi:10.1677/joe.0.1210431 · Cited by 18 · see citing works
Pekary, A. E., Hershman, J. M., REED, A. W., Kannon, R., & Wang, Y.-S. (1986) · Hormone and Metabolic Research · doi:10.1055/s-2007-1012245 · Cited by 15 · see citing works
Rat Heart Thyroxine 5ʼ-Deiodinase is Sensitively Depressed by Amiodarone
Gøtzsche, L. B.-H., Boye, N., Laurberg, P. T., & Andreasen, F. (1989) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198912000-00006 · Cited by 14 · see citing works
Kaplan, M. M., & Breitbart, R. E. (1984) · PubMed · Cited by 13 · see citing works
Ja, C., Mr, G. F., & Zaninovich, Á. A. (1988) · PubMed · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928 · see citing works
“With respect to agents that alter D2 activity, a need for an increased dose of LT4 was reported with initiation of amiodarone therapy in two patients (192), and this drug has been shown to inhibit D2 in rodents (193).”
Self-citationParadigms of dynamic control of thyroid hormone signaling
Bianco, A. C., Dumitrescu, A., Gereben, B., Ribeiro, M. O., Fonseca, T. L., Fernandes, G. W., & Bocco, B. M. L. C. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00275 · Cited by 293 · see citing works
Self-citationThyroid hormone signaling in energy homeostasis and energy metabolism
McAninch, E. A., & Bianco, A. C. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12374 · Cited by 241 · see citing works
Self-citationShi, X., Han, C., Li, C., Mao, J., Wang, W., Xie, X., Li, C., Xu, B., Meng, T., Du, J., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3704 · Cited by 239 · see citing works
Chemistry and Biology in the Biosynthesis and Action of Thyroid Hormones
Mondal, S., Raja, K., Schweizer, U., & Mugesh, G. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201601116 · Cited by 216 · see citing works
Bianco, A. C., Anderson, G., Forrest, D., Galton, V. A., Gereben, B., Kim, B. W., Kopp, P. A., Liao, X. H., Obregon, M. J., Peeters, R. P., et al. (2014) · Thyroid · doi:10.1089/thy.2013.0109 · Cited by 205 · see citing works
Self-citationChatzitomaris, A., Hoermann, R., Midgley, J. E. M., Hering, S., Urban, A., Dietrich, B., Abood, A., Klein, H. H., & Dietrich, J. W. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00163 · Cited by 176 · see citing works
Coordination of hypothalamic and pituitary T3 production regulates TSH expression
Fonseca, T. L., Correa-Medina, M., Campos, M. P. O., Wittmann, G., Werneck-de-Castro, J. P., Arrojo e Drigo, R., Mora-Garzon, M., Ueta, C. B., Caicedo, A., Fekete, C., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci61231 · Cited by 155 · see citing works
Self-citationRole of the type 2 iodothyronine deiodinase (D2) in the control of thyroid hormone signaling
Drigo, R. A. E., Fonseca, T. L., Werneck‐de‐Castro, J. P., & Bianco, A. C. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.08.019 · Cited by 146 · see citing works
Self-citationLocal control of thyroid hormone action: role of type 2 deiodinase
Williams, G. R., & Bassett, J. H. D. (2011) · Journal of Endocrinology · doi:10.1530/joe-10-0448 · Cited by 134 · see citing works
Deiodinases control local cellular and systemic thyroid hormone availability
Köhrle, J., & Frädrich, C. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.09.024 · Cited by 133 · see citing works
The Thyroid Hormone Triiodothyronine Controls Macrophage Maturation and Functions
Perrotta, C., Buldorini, M., Assi, E., Cazzato, D., Palma, C. D., Clementi, E., & Cervia, D. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.10.006 · Cited by 128 · see citing works
Minireview: The Neural Regulation of the Hypothalamic-Pituitary-Thyroid Axis
Costa-e-Sousa, R. H., & Hollenberg, A. N. (2012) · Endocrinology · doi:10.1210/en.2012-1467 · Cited by 123 · see citing works
Subclinical hypothyroidism in childhood — current knowledge and open issues
Salerno, M., Capalbo, D., Cerbone, M., & Luca, F. D. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.100 · Cited by 118 · see citing works
Physiological role and regulation of iodothyronine deiodinases: A 2011 update
Marsili, A., Zavacki, A. M., Harney, J. W., & Larsen, P. R. (2011) · Journal of Endocrinological Investigation · doi:10.1007/bf03347465 · Cited by 101 · see citing works
Cavina, L., van der Born, D., Klaren, P. H. M., Feiters, M. C., Boerman, O. C., & Rutjes, F. P. J. T. (2017) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201601638 · Cited by 98 · see citing works
Understanding selenoprotein function and regulation through the use of rodent models
Kasaikina, M. V., Hatfield, D. L., & Gladyshev, V. N. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.02.018 · Cited by 98 · see citing works
The Deiodinase Trio and Thyroid Hormone Signaling
Bianco, A. C., & da Conceição, R. R. (2018) · Methods in Molecular Biology · doi:10.1007/978-1-4939-7902-8_8 · Cited by 96 · see citing works
Self-citationType 2 deiodinase at the crossroads of thyroid hormone action
Drigo, R. A. E., & Bianco, A. C. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.05.016 · Cited by 95 · see citing works
Self-citationNew insights into the structure and mechanism of iodothyronine deiodinases
Schweizer, U., & Steegborn, C. (2015) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0156 · Cited by 87 · see citing works
Hepburn, A. C., Steele, R. E., Veeratterapillay, R., Wilson, L., Kounatidou, E. E., Barnard, A., Berry, P., Cassidy, J., Moad, M., El‐Sherif, A., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0712-y · Cited by 86 · see citing works
Olker, J. H., Korte, J. J., Denny, J. S., Hartig, P. C., Cardon, M. C., Knutsen, C., Kent, P. M., Christensen, J. P., Degitz, S. J., & Hornung, M. W. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy302 · Cited by 78 · see citing works
Regulation of TRH neurons and energy homeostasis-related signals under stress
Joseph‐Bravo, P., Jaimes-Hoy, L., & Charli, J. (2015) · Journal of Endocrinology · doi:10.1530/joe-14-0593 · Cited by 76 · see citing works
Amiodarone-Induced Thyroid Dysfunction
Danzi, S. E., & Klein, I. L. (2013) · Journal of Intensive Care Medicine · doi:10.1177/0885066613503278 · Cited by 67 · see citing works
Novel thyroid hormone analogues, enzyme inhibitors and mimetics, and their action
Mondal, S., & Mugesh, G. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.04.006 · Cited by 57 · see citing works
Li, N., Jiang, Y., Shan, Z., & Teng, W. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511003552 · Cited by 52 · see citing works
Mild Hypothyroidism in Childhood: Who, When, and How Should Be Treated?
Vigone, M. C., Capalbo, D., Weber, G., & Salerno, M. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2017-00471 · Cited by 51 · see citing works
Foster, J. R., Tinwell, H., & Melching‐Kollmuss, S. (2021) · Archives of Toxicology · doi:10.1007/s00204-020-02961-6 · Cited by 53 · see citing works
Roberts, S. C., Bianco, A. C., & Stapleton, H. M. (2015) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00072 · Cited by 49 · see citing works
Self-citationJabrocka‐Hybel, A., Bednarczuk, T., Bartalena, L., Pach, D., Ruchała, M., Kamiński, G., Kostecka-Matyja, M., & Hubalewska–Dydejczyk, A. (2015) · Endokrynologia Polska · doi:10.5603/ep.2015.0025 · Cited by 47 · see citing works
Amiodarone and Thyroid Dysfunction
Medić, F. (2022) · Acta Clinica Croatica · doi:10.20471/acc.2022.61.02.20 · Cited by 45 · see citing works
Haigis, A.-C., Vergauwen, L., LaLone, C. A., Villeneuve, D. L., O’Brien, J. M., & Knapen, D. (2023) · Toxicological Sciences · doi:10.1093/toxsci/kfad063 · Cited by 38 · see citing works
A review of the peripheral levels of regulation by thyroid hormone
Little, A. G. (2016) · Journal of Comparative Physiology B · doi:10.1007/s00360-016-0984-2 · Cited by 30 · see citing works
Inappropriate Elevation of Serum Thyrotropin Levels in Patients Treated with Axitinib
Ohba, K., Takayama, T., Matsunaga, H., Matsushita, A., Sasaki, S., Oki, Y., Ozono, S., & Nakamura, H. (2012) · Thyroid · doi:10.1089/thy.2012.0378 · Cited by 29 · see citing works
Boucai, L., Salas-Lucia, F., Krishnamoorthy, G. P., Sherman, E. J., Rudin, C. M., Drilon, A. E. D. C., Bianco, A. C., & Fagin, J. A. (2022) · JCO Precision Oncology · doi:10.1200/po.21.00496 · Cited by 21 · see citing works
Self-citationChemie und Biologie der Schilddrüsenhormon‐Biosynthese und ‐Wirkung
Mondal, S., Raja, K., Schweizer, U., & Mugesh, G. (2016) · Angewandte Chemie · doi:10.1002/ange.201601116 · Cited by 19 · see citing works
Kiss, D., Ioja, E., Toth, I., Barany, Z., Jocsak, G., Bartha, T., Horvath, T., & Zsarnovszky, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051440 · Cited by 18 · see citing works
Schweizer, U., Towell, H., Vit, A., Rodriguez-Ruiz, A., & Steegborn, C. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.01.026 · Cited by 18 · see citing works
van Beeren, H. C., Kwakkel, J., Ackermans, M. T., Wiersinga, W. M., Fliers, E., & Boelen, A. (2012) · Thyroid · doi:10.1089/thy.2012.0135 · Cited by 18 · see citing works
Determination of the cardiac drug amiodarone and its N-desethyl metabolite in sludge samples
Montes, R., Rodríguez, I., Casado, J., López‐Sabater, M. C., & Cela, R. (2015) · Journal of Chromatography A · doi:10.1016/j.chroma.2015.03.024 · Cited by 16 · see citing works
Local Regulation of Thyroid Hormone Signaling
Little, A. G. (2017) · Vitamins and hormones · doi:10.1016/bs.vh.2017.06.004 · Cited by 16 · see citing works
Wittmann, G., Harney, J. W., Singru, P. S., Nouriel, S. S., Larsen, P. R., & Lechan, R. M. (2014) · Endocrinology · doi:10.1210/en.2013-2154 · Cited by 14 · see citing works
Self-citationThe heart of the matter: Cardiac manifestations of endocrine disease
Paul, T. V., Binu, A. J., Cherian, K. E., Kapoor, N., Chacko, S. T., & George, O. K. (2017) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_212_17 · Cited by 13 · see citing works
Myocardial Inactivation of Thyroid Hormones in Patients with Aortic Stenosis
Paolino, B. S., Pomerantzeff, P. M. A., Dallan, L. A. O., Gaiotto, F. A., Preite, N. Z., Latronico, A. C., Nicolau, J. C., Bianco, A. C., & Giraldez, R. R. (2017) · Thyroid · doi:10.1089/thy.2016.0514 · Cited by 13 · see citing works
Self-citationMonitoring of deiodinase deficiency based on transcriptomic responses in SH-SY5Y cells
Song, M., Song, M., Choi, H., & Ryu, J. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1018-4 · Cited by 12 · see citing works
Sarapura, V. D., Gordon, D. F., & Samuels, M. H. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-380926-1.10006-9 · Cited by 11 · see citing works
Zhang, X., Jiang, Y., Han, W., Liu, A., Xie, X., Han, C., Fan, C., Wang, H., Zhang, H., Ding, S., et al. (2016) · Biological Trace Element Research · doi:10.1007/s12011-016-0723-2 · Cited by 11 · see citing works
Grineva, E. N., Tsoy, U. A., Karonova, T. L., Andreychenko, T. V., Богданова, Г. А., Vanushko, V. E., Dalmatova, A. B., Данилов, И. Н., Иваниха, E. В., Lebedev, D. S., et al. (2021) · Clinical and experimental thyroidology · doi:10.14341/ket12693 · Cited by 10 · see citing works
Role of type 1 and 2 deiodinases in thyroid metabolism (review)
Artykbaeva, G. (2016) · Problems of Endocrinology · doi:10.14341/probl201662246-52 · Cited by 9 · see citing works
Amiodarone-induced type 2 thyrotoxicosis
Portelli, D., Mifsud, S., Abela, A. G., & Fava, S. (2021) · BMJ Case Reports · doi:10.1136/bcr-2020-238145 · Cited by 9 · see citing works
Ren, B., Wan, S., Liu, L., Qu, M., Wu, H. Q., & Shen, H. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01395-2 · Cited by 9 · see citing works
Sugiyama, K., Kobayashi, S., Kurihara, I., Miyashita, K., Yokota, K., Kohno, T., Noh, J. Y., & Itoh, H. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej20-0307 · Cited by 6 · see citing works
Polypharmacy Is Associated With Amiodarone-Induced Hypothyroidism
Yokoyama, S., Tanaka, Y., Hosomi, K., & Takada, M. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.61412 · Cited by 6 · see citing works
The “slightly” abnormal thyroid test: What is the pediatrician to do?
Gyuricsko, E. (2020) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2020.100770 · Cited by 6 · see citing works
Amiodarone-Induced Thyroid Dysfunction
Leo, S. D., & Braverman, L. E. (2019) · Springer eBooks · doi:10.1007/978-3-319-72102-6_30 · Cited by 6 · see citing works
Deiodinases’ Inhibitors: A Double-Edged Sword
Acampora, L., Miro, C., Cicatiello, A. G., Dentice, M., & Nappi, A. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl40246 · Cited by 6 · see citing works
Su, Q., Zhang, S., Hu, M. L., Wang, Q., Liu, N., Shen, H., Zhang, Y., & Zhang, M. (2018) · Biological Trace Element Research · doi:10.1007/s12011-018-1480-1 · Cited by 5 · see citing works
Drug effects and thyroid function
Feldt-Rasmussen, U., & Rasmussen, Å. K. (2018) · Encyclopedia of Endocrine Diseases · doi:10.1016/b978-0-12-801238-3.96002-1 · Cited by 4 · see citing works
Molnár, I., Szentmiklósi, J., & Somogyiné-Vári, É. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-113831 · Cited by 4 · see citing works
Miller, B. T., Ueta, C. B., Lau, V. C., Jacomino, K. G., Wasserman, L. M., & Kim, B. W. (2012) · Endocrinology · doi:10.1210/en.2012-1117 · Cited by 4 · see citing works
Two patients with atypical low triiodothyronine syndrome: primary deiodinase abnormalities?
Tevaarwerk, G. J. M. (2014) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-13-0055 · Cited by 1 · see citing works
Detecting Toxicity Pathways with a Formal Framework Based on Equilibrium Changes
Miraglio, B., Bernot, G., Comet, J., & Faverney, C. R.-D. (2017) · Lecture notes in computer science · doi:10.1007/978-3-319-67471-1_12 · Cited by 1 · see citing works
UNDERSTANDING OF FUNCTIONS OF SELENOPROTEINS AND DIETARY SELENIUM BY USING ANIMAL MODELS
Kasaikina, M. V. (2011) · Lincoln (University of Nebraska) · Cited by 1 · see citing works
Gordon, D. F., & Ridgway, E. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00074-3 · Cited by 1 · see citing works
Jamshidi, A. A., & Lamouki, G. R. R. (2021) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2021.102473 · Cited by 1 · see citing works
Maseko, T. (2014) · Minerva Access (University of Melbourne)
Amiodarona y disfunción tiroidea
Rizzo, L. F. L., & Bruno, O. D. (2012) · DOAJ (DOAJ: Directory of Open Access Journals)
Drug Repurposing Patent Applications October–December 2022
Mucke, H. A. (2023) · Assay and Drug Development Technologies · doi:10.1089/adt.2023.008
Quarde, A. (2023) · Wiley eBooks · doi:10.1002/9781119863564.ch2
Sinkó, R., Katkó, M., Tóth, G., Kovács, G. L., Dohán, O., Fülöp, T., Costa, P., Dorogházi, B., Kővári, D., Nagy, E. V., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae514
Jassim, A. F., & Mashan, Q. (2024) · International Journal of Clinical Biochemistry and Research · doi:10.18231/j.ijcbr.2024.027
Drug effects and thyroid function
Klose, M., Feldt‐Rasmussen, U., & Rasmussen, Å. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00300-9
- Authors
- Rosene, M. L., Wittmann, G., Arrojo e Drigo, R., Singru, P. S., Lechan, R. M., & Bianco, A. C.
- Affiliations
- University of Miami (US)
- Tupper Research Institute and Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism (G.W., P.S.S., R.M.L.), Tufts Medical Center and Department of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts 02111
- Division of Endocrinology, Diabetes, and Metabolism (M.L.R., R.A.e.D., A.C.B.), University of Miami Miller School of Medicine, Miami, Florida 33136
- Tufts University (US)
- Corresponding author
- Bianco, Antonio C.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2010-10-06
- Volume
- 151
- Issue
- 12
- Pages
- 5961-5970
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- PMC
- PMC2999495
- OpenAlex
- W1996253654
- Cited by
- 72
- References
- 39
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 5 · 2020: 3 · 2019: 3 · 2018: 6 · 2017: 9 · 2016: 6 · 2015: 7 · 2014: 5 · 2013: 5 · 2012: 7
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Endocrinology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 37021, R01DK058538, R01DK037021, DK 58538, R56DK037021)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- amiodarone, desethylamiodarone, type 2 deiodinase, TSH elevation, thyroid-stimulating hormone, non-competitive inhibition, T3, thyrotropin-releasing hormone, pituitary gland, adverse drug reactions, antiarrhythmic drugs
- MeSH terms
- Iodothyronine Deiodinase Type II, Amiodarone, Animals, Anti-Arrhythmia Agents, Cell Line, Iodide Peroxidase, Mice, Inbred C57BL, Thyrotropin, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review